原发性胆汁性胆管炎合并胃弥漫性大B细胞淋巴瘤1例报告
DOI: 10.3969/j.issn.1001-5256.2021.03.034
利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:冯丽娜、黄剑洁负责课题设计,资料分析,撰写论文;涂芷馨、王妍、张晓雪、马博参与收集数据,修改论文;温晓玉、金清龙负责拟定写作思路,指导撰写文章并最后定稿。
Primary biliary cholangitis with gastric diffuse large B-cell lymphoma: A case report
-
-
关键词:
- 原发性胆汁性胆管炎 /
- 淋巴瘤, 大B细胞, 弥漫性 /
- 利妥昔单抗
-
Key words:
- Primary Biliary Cholangitis /
- Lymphoma, Large B-Cell, Diffuse /
- Rituximab
-
[1] YAMAGIWA S, KAMIMURA H, TAKAMURA M, et al. Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance[J]. World J Gastroenterol, 2014, 20(10): 2606-2612. DOI: 10.3748/wjg.v20.i10.2606 [2] KOUMATI E, PALASSOPOULOU M, MATSOUKA P, et al. Multiple autoimmune propensity and B-non-Hodgkin lymphoma: Cause or effect?[J]. Autoimmune Dis, 2011, 2011: 841325. http://europepmc.org/articles/PMC3112510/ [3] SMEDBY KE, HJALGRIM H, ASKLING J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype[J]. J Natl Cancer Inst, 2006, 98(1): 51-60. DOI: 10.1093/jnci/djj004 [4] ALEXANDER DD, MINK PJ, ADAMI HO, et al. The non-Hodgkin lymphomas: A review of the epidemiologic literature[J]. Int J Cancer, 2007, 120(Suppl 12): 1-39. http://www.ncbi.nlm.nih.gov/pubmed/17405121 [5] GOLDIN LR, LANDGREN O. Autoimmunity and lymphomagenesis[J]. Int J Cancer, 2009, 124(7): 1497-1502. DOI: 10.1002/ijc.24141 [6] FLOREANI A, SPINAZZÈ A, CABALLERIA L, et al. Extrahepatic malignancies in primary biliary cirrhosis: A comparative study at two European centers[J]. Clin Rev Allergy Immunol, 2015, 48(2-3): 254-262. DOI: 10.1007/s12016-014-8446-7 [7] KANELLOPOULOU T, ALEXOPOULOU A, KONTOPIDOU FN, et al. Development of non-Hodgkin's lymphoma in a patient with primary biliary cirrhosis: A case report and review of the literature[J]. Ann Gastroenterol, 2011, 24(2): 125-128. http://pubmedcentralcanada.ca/pmcc/articles/PMC3959296/ [8] PANJALA C, TALWALKAR JA, LINDOR KD. Risk of lymphoma in primary biliary cirrhosis[J]. Clin Gastroenterol Hepatol, 2007, 5(6): 761-764. DOI: 10.1016/j.cgh.2007.02.020 [9] TIAN H. Rheumatic and skin manifestations associated with autoimmune liver diseases[J]. J Clin Hepatol, 2018, 34(9): 2021-2026. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2018.09.041田辉. 自身免疫性肝病相关性风湿病样及皮肤表现[J]. 临床肝胆病杂志, 2018, 34(9): 2021-2026. DOI: 10.3969/j.issn.1001-5256.2018.09.041 [10] ZHANG W, FENG S, YAN S, et al. Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort[J]. Rheumatology (Oxford), 2010, 49(3): 571-577. DOI: 10.1093/rheumatology/kep404 [11] GOODNOW CC. Multistep pathogenesis of autoimmune disease[J]. Cell, 2007, 130(1): 25-35. DOI: 10.1016/j.cell.2007.06.033 [12] JARDIN F. Development of autoimmunity in lymphoma[J]. Expert Rev Clin Immunol, 2008, 4(2): 247-266. DOI: 10.1586/1744666X.4.2.247 [13] MYERS RP, SWAIN MG, LEE SS, et al. B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid[J]. Am J Gastroenterol, 2013, 108(6): 933-941. DOI: 10.1038/ajg.2013.51 [14] XIA Y, ZHOU ZW. Treatment of primary gastric lymphoma[J]. Chin J Gastrointestinal Surg, 2017, 20(11): 1227-1230. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL200919019.htm夏奕, 周志伟. 原发性胃淋巴瘤的治疗策略[J]. 中华胃肠外科杂志, 2017, 20(11): 1227-1230. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL200919019.htm [15] TSUDA M, MORITOKI Y, LIAN ZX, et al. Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid[J]. Hepatology, 2012, 55(2): 512-521. DOI: 10.1002/hep.24748 [16] KHANNA A, JOPSON L, HOWEL D, et al. Rituximab is ineffective for treatment of fatigue in primary biliary cholangitis: A phase 2 randomized controlled trial[J]. Hepatology, 2019, 70(5): 1646-1657. DOI: 10.1002/hep.30099 [17] DHIRAPONG A, LLEO A, YANG GX, et al. B cell depletion therapy exacerbates murine primary biliary cirrhosis[J]. Hepatology, 2011, 53(2): 527-535. DOI: 10.1002/hep.24044 [18] YIN YF, ZHANG X. B cell depletion in treating primary biliary cirrhosis: Pros and cons[J]. World J Gastroenterol, 2012, 18(30): 3938-3940. DOI: 10.3748/wjg.v18.i30.3938 [19] TAJIRI K, TSUNEYAMA K, MIYAZONO T, et al. A case of primary biliary cirrhosis that progressed rapidly after treatment involving rituximab[J]. Case Rep Gastroenterol, 2013, 7(1): 195-201. DOI: 10.1159/000351173